Site search
2831 results for '' found
MEMENTO - A Phase 4, Single-arm, Open-label Clinical Study to Evaluate Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Assess the Impact on Myocardial Structure w
MEMENTO - A Phase 4, Single-arm, Open-label Clinical Study to Evaluate Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Assess the Impact on Myocardial Structure w
/
MEL-SELF: A randomised controlled trial of a patient-led surveillance compared to clinician-led surveillance in people treated for early-stage melanoma (stage 0/I/II) (ACTRN12621000176864)
MEL-SELF: A randomised controlled trial of a patient-led surveillance compared to clinician-led surveillance in people treated for early-stage melanoma (stage 0/I/II) (ACTRN12621000176864)
/
The Metformin Aneurysm Trial (MAT) (ACTRN12618001707257)
The Metformin Aneurysm Trial (MAT) (ACTRN12618001707257)
/
Melanoma Margins Trial (MelMarT): A Phase III, multi-centre, multi-national randominsed control trial investigating 1cm v 2cm wide excision margins for primary cutaneous melanoma (ACTRN1261400066
Melanoma Margins Trial (MelMarT): A Phase III, multi-centre, multi-national randominsed control trial investigating 1cm v 2cm wide excision margins for primary cutaneous melanoma (ACTRN1261400066
/
MASTERPLAN: A randomised phase II study of MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease (NCT04089150)
MASTERPLAN: A randomised phase II study of MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease (NCT04089150)
/
A Phase 1a/1b, First-in-Human, Open Label Study to Assess the Safety, Tolerability, and Pharmacokinetics of PMC-309 (Anti-VISTA), as Monotherapy and Combined With Pembrolizumab, in Patients With
A Phase 1a/1b, First-in-Human, Open Label Study to Assess the Safety, Tolerability, and Pharmacokinetics of PMC-309 (Anti-VISTA), as Monotherapy and Combined With Pembrolizumab, in Patients With
/
A double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of intravenous ganaxolone in status epilepticus (NCT04391569)
A double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of intravenous ganaxolone in status epilepticus (NCT04391569)
/
A Phase 3, Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related Epilepsy (TrustTSC) (NC
A Phase 3, Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related Epilepsy (TrustTSC) (NC
/
Percutaneous Decannulation of Extracorporeal Membrane Oxygenation Using MANTA Vascular Closure Device (ACTRN12621000791831)
Percutaneous Decannulation of Extracorporeal Membrane Oxygenation Using MANTA Vascular Closure Device (ACTRN12621000791831)
/
Phase 3 Study of Teclistamab in Combination with Lenalidomide versus Lenalidomide Alone in Participants with Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell
Phase 3 Study of Teclistamab in Combination with Lenalidomide versus Lenalidomide Alone in Participants with Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell
/